These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2511919)

  • 1. The alginate raft: a scintigraphic evaluation.
    McKay AP; Wraight EP; Hunter JO
    Br J Clin Pract Suppl; 1989 Feb; 66():20-4; discussion 35-6. PubMed ID: 2511919
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of gastro-oesophageal reflux disorders. Algicon: a product overview.
    Gimbol MJ
    Br J Clin Pract Suppl; 1989 Feb; 66():2-4; discussion 35-6. PubMed ID: 2511918
    [No Abstract]   [Full Text] [Related]  

  • 3. Algicon in the management of gastro-oesophageal reflux.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of gastro-oesophageal reflux disorders. Focus on algicon. Proceedings of a symposium. Sheffield, UK, 17th September 1988.
    Br J Clin Pract Suppl; 1989 Feb; 66():1-64. PubMed ID: 2511915
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastro-oesophageal pH measurements during reflux induced by provocative tests.
    Baldi F; Longanesi A; Ferrarini F; Ragazzini M; Michieletti G
    Br J Clin Pract Suppl; 1989 Feb; 66():10-4; discussion 35-6. PubMed ID: 2511916
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
    Ward AE
    Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.
    Lang GD; Dougall A
    Br J Clin Pract Suppl; 1989 Feb; 66():48-51; discussion 61-4. PubMed ID: 2556175
    [No Abstract]   [Full Text] [Related]  

  • 8. A study of Algicon, an antacid-alginate preparation, in patients with reflux oesophagitis.
    Maxton DG; Miller JP; Whorwell PJ; Butler JK
    Br J Clin Pract; 1988 Sep; 42(9):368-71. PubMed ID: 3075928
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and tolerance of Algicon in patients with reflux oesophagitis.
    Lancaster Smith MJ; Miller JP; Whorwell PJ
    Br J Clin Pract Suppl; 1989 Feb; 66():38-42; discussion 61-4. PubMed ID: 2511921
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of 111In-labeled alginate to study the pH dependence of alginic acid anti-esophageal reflux barrier.
    Knight LC; Maurer AH; Ammar IA; Siegel JA; Fisher RS; Malmud LS
    Int J Rad Appl Instrum B; 1988; 15(5):563-71. PubMed ID: 3254879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Algicon on the ultrastructure of the mucosa of subjects with reflux oesophagitis.
    Trabucchi E; Foschi D; Radaelli E; Callioni F; Montorsi W
    Br J Clin Pract Suppl; 1989 Feb; 66():43-7; discussion 61-4. PubMed ID: 2511922
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Algicon and ranitidine in the therapy of reflux oesophagitis: preliminary results.
    Pace F; Sangaletti O; Bianchi Porro G
    Br J Clin Pract Suppl; 1989 Feb; 66():59-60; discussion 61-4. PubMed ID: 2511924
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty-four-hour oesophageal pH monitoring of reflux episodes: effect of Algicon.
    Devis G; de Rop H; Peters O
    Br J Clin Pract Suppl; 1989 Feb; 66():15-7; discussion 35-6. PubMed ID: 2511917
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
    Guerre J; Neuman M; Bouchet J
    Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
    [No Abstract]   [Full Text] [Related]  

  • 15. [A successful treatment of gastro-oesophageal reflux in infancy with Gaviscon].
    Gross-Kieselstein E; Branski D; Abrahamov A
    Harefuah; 1975 Oct; 89(7):327-9. PubMed ID: 171200
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison between cisapride and Gaviscon with Carobel in the treatment of gastro-oesophageal reflux in infancy.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Ir Med J; 1992; 85(4 Suppl):14. PubMed ID: 1490841
    [No Abstract]   [Full Text] [Related]  

  • 17. The mode of action alginic acid compound in the reduction of gastroesophageal reflux.
    Malmud LS; Charkes ND; Littlefield J; Reilley J; Stern H; Rosenberg R; Fisher RS
    J Nucl Med; 1979 Oct; 20(10):1023-8. PubMed ID: 231639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 20. In-vivo anti-reflux and raft properties of alginates.
    Lambert JR; Korman MG; Nicholson L; Chan JG
    Aliment Pharmacol Ther; 1990 Dec; 4(6):615-22. PubMed ID: 2129648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.